淡定的小馒头
Lv3
250 积分
2022-12-30 加入
-
Mesenchymal Stem Cells for Ischemic Stroke: Hope or Hype?
12天前
已完结
-
Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke
12天前
已完结
-
Clustering of EORTC QLQ-C30 health-related quality of life scales across several cancer types: Validation study
1个月前
已完结
-
Cadonilimab Combined with Chemotherapy with or Without Bevacizumab for First-Line Treatment of Recurrent or Metastatic Cervical Cancer
2个月前
已关闭
-
Cadonilimab combined with chemotherapy with or without bevacizumab as first-line treatment in recurrent or metastatic cervical cancer (COMPASSION-13): a phase 2 study
2个月前
已关闭
-
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
3个月前
已完结
-
Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial
4个月前
已完结
-
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
4个月前
已完结
-
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994
4个月前
已完结
-
Adjuvant chemotherapy following chemoradiotherapy as primary treatment for locally advanced cervical cancer versus chemoradiotherapy alone (OUTBACK): an international, open-label, randomised, phase 3 trial
5个月前
已完结